ACTIVATION OF CD21 AND CD 23

CD21 和 CD 23 的激活

基本信息

  • 批准号:
    7349572
  • 负责人:
  • 金额:
    $ 6.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-05-01 至 2007-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Epstein-Barr virus (EBV) EBNA2 and Kaposi's sarcoma-associated herpesvirus (KSHV) replication and transcription activator (RTA) are recruited to their responsive elements through interaction with a Notch-mediated transcription factor, RBP-Jk. In particular, RTA and EBNA2 interactions with RBP-Jk are essential for the lytic replication of KSHV and expression of B-cell activation markers CD21 and CD23a, respectively. Here, we demonstrate that like EBV EBNA2, KSHV RTA strongly induces CD21 and CD23a expression through RBP-Jk binding sites in the first intron of CD21 and in the CD23a core promoter, respectively. However, unlike EBV EBNA2, which alters immunoglobulin mu (Igmu) and c-myc gene expression, RTA did not affect Igmu and c-myc expression, indicating that KSHV RTA targets the Notch signal transduction pathway in a manner similar to but distinct from that of EBV EBNA2. Furthermore, RTA-induced expression of CD21 glycoprotein, which is an EBV receptor, efficiently facilitated EBV infection. In addition, RTA-induced CD23 glycoprotein underwent proteolysis and gave rise to soluble CD23 (sCD23) molecules in B lymphocytes and KSHV-infected primary effusion lymphocytes. sCD23 then stimulated primary human lymphocytes. These results demonstrate that cellular CD21 and CD23a are common targets for B lymphotropic gammaherpesviruses and that KSHV RTA regulates RBP-Jk-mediated cellular gene expression, which ultimately provides a favorable milieu for viral reproduction in the infected host.
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得主要资金,因此可以在其他CRISP条目中表示。所列机构为中心,不一定是研究者所在机构。EB病毒(EBV)EBNA 2和卡波西肉瘤相关疱疹病毒(KSHV)复制和转录激活因子(RTA)通过与Notch介导的转录因子RBP-Jk相互作用被招募到其应答元件。特别是,RTA和EBNA 2与RBP-Jk的相互作用分别对KSHV的裂解复制和B细胞活化标志物CD 21和CD 23 a的表达至关重要。在这里,我们证明,像EBV EBNA 2,KSHV RTA强烈诱导CD 21和CD 23 a的表达,通过RBP-Jk结合位点的第一个内含子的CD 21和CD 23 a的核心启动子,分别。然而,与改变免疫球蛋白mu(Igmu)和c-myc基因表达的EBV EBNA 2不同,RTA不影响Igmu和c-myc表达,表明KSHV RTA以与EBV EBNA 2类似但不同的方式靶向Notch信号转导途径。此外,RTA诱导的CD 21糖蛋白(EBV受体)的表达有效地促进了EBV感染。此外,RTA诱导的CD 23糖蛋白发生蛋白水解,并在B淋巴细胞和KSHV感染的原发性渗出液淋巴细胞中产生可溶性CD 23(sCD 23)分子。然后sCD 23刺激原代人淋巴细胞。这些结果表明,细胞CD 21和CD 23 a是B嗜淋巴细胞γ疱疹病毒的常见靶标,并且KSHV RTA调节RBP-Jk介导的细胞基因表达,这最终为感染宿主中的病毒繁殖提供了有利的环境。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HEESON CHANG其他文献

HEESON CHANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HEESON CHANG', 18)}}的其他基金

NON-HUMAN PRIMATE MODEL OF KAPOSI?S SARCOMA-ASSOCIATED HERPESVIRUS INFECTION
卡波西肉瘤相关疱疹病毒感染的非人灵长类动物模型
  • 批准号:
    7715514
  • 财政年份:
    2008
  • 资助金额:
    $ 6.63万
  • 项目类别:
KAPOSI?S SARCOMA-ASSOCIATED HERPESVIRUS GENE EXPRESSION
卡波西肉瘤相关疱疹病毒基因表达
  • 批准号:
    7349564
  • 财政年份:
    2006
  • 资助金额:
    $ 6.63万
  • 项目类别:

相似国自然基金

CD21影响CD19-CAR-T治疗B细胞恶性肿瘤的作用机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

CD21 directed CAR-T cell immunotherapy for relapsed/refractory T-cell acute lymphoblastic leukaemia (T-ALL)
CD21定向CAR-T细胞免疫疗法治疗复发/难治性T细胞急性淋巴细胞白血病(T-ALL)
  • 批准号:
    MR/T000821/1
  • 财政年份:
    2020
  • 资助金额:
    $ 6.63万
  • 项目类别:
    Research Grant
Complement and CR2/CD21 in the Immune Pathogenesis of HIT
HIT 免疫发病机制中的补体和 CR2/CD21
  • 批准号:
    10077790
  • 财政年份:
    2018
  • 资助金额:
    $ 6.63万
  • 项目类别:
Disconnecting CR2/CD21 from Its C3d Ligand to Ameliorate Lupus
断开 CR2/CD21 与其 C3d 配体的连接以改善狼疮
  • 批准号:
    8492301
  • 财政年份:
    2013
  • 资助金额:
    $ 6.63万
  • 项目类别:
Molecular and cellular mechanisms of synapse-mediated spread of Epstein Barr virus: overcoming the CD21-restricted cellular tropism.
Epstein Barr 病毒突触介导传播的分子和细胞机制:克服 CD21 限制的细胞向性。
  • 批准号:
    MR/J002046/1
  • 财政年份:
    2012
  • 资助金额:
    $ 6.63万
  • 项目类别:
    Research Grant
DOUBLE POSITIVE CD21+CD27+ B CELLS ARE IN MUCOSAL AND PERIPHERAL TISSUES
粘膜和外周组织中存在双阳性 CD21 CD27 B 细胞
  • 批准号:
    8358167
  • 财政年份:
    2011
  • 资助金额:
    $ 6.63万
  • 项目类别:
Regulation of CR2/CD21 Expression and Activation
CR2/CD21 表达和激活的调节
  • 批准号:
    7880369
  • 财政年份:
    2009
  • 资助金额:
    $ 6.63万
  • 项目类别:
Formins (FHOS) in CD21-mediated signaling & virus entry
CD21 介导的信号传导中的福尔明 (FHOS)
  • 批准号:
    7846459
  • 财政年份:
    2009
  • 资助金额:
    $ 6.63万
  • 项目类别:
Formins (FHOS) in CD21-mediated signaling & virus entry
CD21 介导的信号传导中的福尔明 (FHOS)
  • 批准号:
    6870631
  • 财政年份:
    2005
  • 资助金额:
    $ 6.63万
  • 项目类别:
Formins (FHOS) in CD21-mediated signaling & virus entry
CD21 介导的信号传导中的福尔明 (FHOS)
  • 批准号:
    7024998
  • 财政年份:
    2005
  • 资助金额:
    $ 6.63万
  • 项目类别:
Formins (FHOS) in CD21-mediated signaling & virus entry
CD21 介导的信号传导中的福尔明 (FHOS)
  • 批准号:
    7587344
  • 财政年份:
    2005
  • 资助金额:
    $ 6.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了